Regression analysis of restricted mean survival time based on pseudo-observations
For patients searching for how to qualify for glp 1 for weight loss, showing commitment to diet and activity often strengthens the case for medical approval
However, if one needs reductions in both fasting and postprandial glucose levels a longer acting agent such as repaglinide is a better choice
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Cortes TM, Vasquez L, Serra MC, Robbins R, Stepanenko A, Brown K, Barrus H, Campos A, Espinoza SE, Musi N
The molecular basis of G protein-coupled receptor activation
While there is potential mechanistic overlap with DPP-4 inhibitors or dual GLP/GIP receptor agonists we focus the current review on GLP-1RAs due to preponderance and availability of longer-term data, as well as the significantly higher market penetrance of this drug class